Skip to main content

Table 4 Medication use by ethnicity

From: Ethnic differences in the occurrence of acute coronary syndrome: results of the Malaysian National Cardiovascular Disease (NCVD) Database Registry (March 2006 - February 2010)

Medication use

Ethnic group

 

 χ2**

df

 P#

Malays

Chinese

Indians

Others*

Antiplatelets

       

Aspirin (%)

6092 (94.4)

2769 (94.1)

2851 (94.2)

649 (95.6)

2.6

3

0.454

Other antiplatelets (%)

4312 (68.5)

2222 (77.0)

2178 (73.0)

440 (73.0)

75.6

3

0.000

Anticoagulants

       

Heparin (%)

907 (15.0)

202 (7.3)

281 (9.7)

55 (9.8)

128.9

3

0.000

LMWH (%)

3340 (54.1)

1882 (66.2)

2033 (68.6)

435 (68.5)

282.1

3

0.000

Antihypertensives

       

β-blockers (%)

4238 (67.6)

2052 (71.2)

2067 (69.5)

418 (68.9)

12.3

3

0.060

ACEI (%)

3899 (62.4)

1666 (58.4)

1814 (61.1)

337 (55.9)

19.8

3

0.000

ARB (%)

468 (7.8)

242 (8.7)

304 (10.5)

59 (10.4)

20.3

3

0.000

Diuretics (%)

2016 (32.7)

798 (28.3)

888 (30.2)

196 (33.2)

19.8

3

0.000

CCB (%)

895 (14.8)

409 (14.7)

509 (17.4)

82 (14.5)

12.1

3

0.007

Anti-diabetic agents

       

OHA (%)

1599 (26.1)

712 (25.4)

1157 (39.3)

112 (19.8)

217.9

3

0.000

Insulin (%)

1522 (24.7)

586 (20.8)

978 (33.1)

104 (18.2)

140.7

3

0.000

Statins

       

Statins (%)

5833 (91.0)

2700 (92.1)

2737 (90.8)

646 (95.1)

16.6

3

0.001

  1. Categorical variables are expressed as number (%).
  2. *Others: Indigenous (Orang Asli), Kadazan, Melanau, Murut, Bajau, Bidayuh, Iban (minor ethnic groups) and other non-Malaysians.
  3. **Pearson Chi-Square.
  4. #P value.
  5. LMWH: Low Molecular Weight Heparin.
  6. ACEI: Angiotensin Converting Enzyme Inhibitors.
  7. ARB: Angiotensin Receptor Blockers.
  8. CCB: Calcium Channel Blockers.
  9. OHA: Oral Hypoglycemic Agent.